After presenting comparable docking results last year—and using them to prospectively identify drug candidates on difficult targets—Deep Origin welcomes Isomorphic Labs to the frontier
After presenting comparable docking results last year—and using them to prospectively identify drug candidates on difficult targets—Deep Origin welcomes Isomorphic Labs to the frontier